Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2023-09-27
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Lumbar Discectomy With Annular Closure
NCT03986580
Lumbar Discectomy Control Study, Risk Factors for Reherniation
NCT02477176
A Post Marketing Surveillance Study
NCT03366779
Interbody Systems: Post Market Clinical Follow-up Study
NCT04911257
Incidence of Large Annular Defects in Primary Lumbar Discectomy Patients
NCT03252691
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Discectomy + annular closure
All patients treated with lumbar discectomy and implantation of an annular closure device
Annular closure
Lumbar discectomy patients treated with Annular Closure Device BARRICAID
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Annular closure
Lumbar discectomy patients treated with Annular Closure Device BARRICAID
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Intrinsic Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David H Kim, MD
Role: STUDY_CHAIR
New England Baptist Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopedic Institute of Western Kentucy
Paducah, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.